Liver elastography reports are filled with acronyms and numbers that can seem confusing at first glance. However, understanding these key metrics is crucial for grasping the assessment of your liver health. This article breaks down three common and important parameters: kPa (kilopascals), CAP (Controlled Attenuation Parameter), and UAP (Ultrasound Attenuation Parameter).
These metrics provide non-invasive ways to evaluate two critical aspects of liver health: fibrosis (scarring) and steatosis (fatty change).
1. Liver Stiffness (Fibrosis) - Measured in kPa
kPa (kilopascals)
What it measures: Liver Stiffness (a surrogate marker for Liver Fibrosis).
How it works: Elastography techniques, such as Transient Elastography (TE, like FibroScan®) or Shear Wave Elastography (SWE, found on various ultrasound systems), measure how fast a small mechanical shear wave travels through the liver. Stiffer (more fibrotic or scarred) liver tissue allows these waves to travel faster.
Significance: The result is given in kilopascals (kPa).
- Higher kPa values generally indicate increased liver stiffness, suggesting more significant liver fibrosis.
- Lower kPa values point to a softer, more normal liver with less scarring.
The kPa value helps doctors stage the degree of liver fibrosis, ranging from F0 (no fibrosis) to F4 (cirrhosis). The exact kPa cut-off values for each stage can vary depending on the cause of liver disease (e.g., Hepatitis C, NAFLD, alcohol-related liver disease) and the specific elastography device used. FibroAI takes these factors into account when providing an interpretation.
2. Liver Steatosis (Fatty Liver) - Measured by Attenuation Parameters
Liver steatosis, or fatty liver, is the accumulation of excess fat in liver cells. Several elastography systems can also quantify steatosis using parameters that measure how much the ultrasound beam attenuates (weakens) as it passes through the liver. Fat causes more attenuation.
CAP (Controlled Attenuation Parameter)
What it measures: Liver Steatosis (Fat Content).
Associated Machine: Primarily with FibroScan® (Echosens) devices.
How it works: CAP measures the degree of ultrasound attenuation at the specific frequency used by the FibroScan probe.
Significance: The result is given in decibels per meter (dB/m).
- Higher CAP values suggest a greater amount of fat in the liver.
- Lower CAP values indicate less liver fat.
CAP scores help grade steatosis (e.g., S0, S1, S2, S3), with higher grades indicating more severe fatty liver. For example, a CAP score below ~238-248 dB/m might indicate no significant steatosis (S0), while scores above ~280-290 dB/m could suggest severe steatosis (S3), though these cutoffs also need careful clinical correlation and can vary.
UAP (Ultrasound Attenuation Parameter) & Similar Metrics
What it measures: Liver Steatosis (Fat Content).
Associated Machines: Various ultrasound systems from different manufacturers (e.g., Mindray, GE, Samsung, Siemens) offer their own proprietary methods for measuring ultrasound attenuation to quantify steatosis. These may be called UAP, Attenuation Imaging (ATI), Attenuation Coefficient (AC), UGAP (Ultrasound-Guided Attenuation Parameter), etc.
How it works: Similar to CAP, these parameters measure the rate at which the ultrasound signal loses energy as it passes through liver tissue. Fatty tissue causes greater attenuation.
Significance: Results are often given in units like dB/cm/MHz (decibels per centimeter per megahertz) or similar, depending on the specific system.
- Higher values generally indicate more liver fat.
- Lower values suggest less liver fat.
Each manufacturer typically provides its own reference ranges and interpretative guidelines for their specific attenuation parameter. It\'s important that the interpretation is based on the specific system used.
Why Are These Metrics Important?
Together, kPa, CAP, and UAP (or similar attenuation metrics) provide a comprehensive, non-invasive assessment of liver health. They help doctors:
- Detect and stage liver fibrosis and steatosis.
- Identify individuals at risk for progressive liver disease.
- Monitor the liver\'s response to treatment or lifestyle changes.
- Make informed decisions about patient management.
Understanding these metrics empowers patients to have more informed discussions with their healthcare providers about their liver health and any necessary next steps.
This article provides general information about elastography metrics. The interpretation of your specific results should always be done by a qualified healthcare professional who can consider your complete clinical picture, the specific device used, and relevant medical guidelines. This information is not a substitute for professional medical advice.